{"id":"placebo-eflow-cs-nebulizer","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The eFlow (CS) nebulizer uses vibrating mesh technology to generate aerosol particles optimized for deep lung penetration. As a placebo formulation in clinical trials, it serves as a control device to evaluate the efficacy of active pharmaceutical agents delivered via this nebulization platform. The device itself is not a drug but rather a delivery system for inhaled therapies.","oneSentence":"Placebo eFlow (CS) is a vibrating mesh nebulizer device designed to deliver aerosolized medications to the lungs with enhanced efficiency and patient convenience.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:26:55.572Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in phase 3 clinical trials for inhaled drug delivery"}]},"trialDetails":[{"nctId":"NCT02347761","phase":"PHASE3","title":"Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2015-02","conditions":"COPD","enrollment":653},{"nctId":"NCT02347774","phase":"PHASE3","title":"Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2015-02","conditions":"COPD, Chronic Obstructive Pulmonary Disease","enrollment":641}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo eFlow (CS) nebulizer","genericName":"Placebo eFlow (CS) nebulizer","companyName":"Sunovion Respiratory Development Inc.","companyId":"sunovion-respiratory-development-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"The Placebo eFlow (CS) nebulizer is a device used in a clinical trial to compare the efficacy and safety of SUN-101 against placebo in patients with Chronic Obstructive Pulmonary Disease (COPD). The device delivers a placebo treatment via nebulization, which is a small molecule modality, as part of a randomized, double-blind, placebo-controlled trial.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}